EMILIE MAS

Dr EMILIE MAS

Medical Scientist-Head Mass Spectrometry

Adelaide Medical School

Faculty of Health and Medical Sciences


Cardiovascular disease, Inflammation, Oxidative stress, Lipids, Mass spectrometry

Areas of interest:
- Analytical chemistry
- Mass spectrometry
- Lipid metabolism, Omega- 3 Fatty Acids
- Inflammation, Cardiovascular diseases
- Oxidative stress, antioxidants and biomarkers

    Expand
  • Journals

    Year Citation
    2018 Barden, A., Shinde, S., Phillips, M., Beilin, L., Mas, E., Hodgson, J., . . . Mori, T. (2018). The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus. Prostaglandins Leukotrienes and Essential Fatty Acids, 133, 29-34.
    DOI Scopus3 WoS1
    2018 Barden, A., Phillips, M., Hill, L., Fletcher, E., Mas, E., Loh, P., . . . Corcoran, T. (2018). Antiemetic doses of dexamethasone and their effects on immune cell populations and plasma mediators of inflammation resolution in healthy volunteers. Prostaglandins Leukotrienes and Essential Fatty Acids, 139, 31-39.
    DOI
    2017 Barden, A., Chavez, V., Phillips, M., Mas, E., Beilin, L., Croft, K., . . . Puddey, I. (2017). A randomized trial of effects of alcohol on cytochrome P450 eEicosanoids, mediators of inflammation resolution, and blood pressure in men. Alcoholism: Clinical and Experimental Research, 41(10), 1666-1674.
    DOI
    2017 See, V., Mas, E., Prescott, S., Beilin, L., Burrows, S., Barden, A., . . . Mori, T. (2017). Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 126, 126-132.
    DOI
    2017 Mas, E. (2017). Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans. Prostaglandins, Leukotrienes and Essential Fatty Acids.
    2017 Silbert, B., Ho, K., Lipman, J., Roberts, J., Corcoran, T., Morgan, D., . . . Mori, T. (2017). Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?. Antioxid Redox Signal, 26(5), 221-226.
    DOI Europe PMC5
    2016 Barden, A., Moghaddami, M., Mas, E., Phillips, M., Cleland, L., & Mori, T. (2016). Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids, 107, 24-29.
    DOI Scopus43 WoS38 Europe PMC27
    2016 See, V., Mas, E., Burrows, S., O'Callaghan, N., Fenech, M., Prescott, S., . . . Mori, T. (2016). Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial. Prostaglandins Leukotrienes and Essential Fatty Acids, 112, 50-55.
    DOI Scopus7 WoS6 Europe PMC2
    2016 Corcoran, T., Mas, E., Barden, A., Roberts, L., Mori, T., & O'Loughlin, E. (2016). Controlled moderate hypovolaemia in healthy volunteers is not associated with the development of oxidative stress assessed by plasma F2-isoprostanes and isofurans. Prostaglandins and Other Lipid Mediators, 124, 34-38.
    DOI Scopus1
    2016 Bondonno, N., Bondonno, C., Rich, L., Mas, E., Shinde, S., Ward, N., . . . Croft, K. (2016). Acute effects of quercetin-3-O-glucoside on endothelial function and blood pressure: A randomized dose-response study. American Journal of Clinical Nutrition, 104(1), 97-103.
    DOI Scopus10 Europe PMC4
    2016 Silbert, B., Ho, K., Lipman, J., Roberts, J., Corcoran, T., Morgan, D., . . . Mori, T. (2016). Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study. Critical Care Medicine, 44(10), e923-e929.
    DOI Scopus9 Europe PMC7
    2016 Barden, A., O Callaghan, N., Burke, V., Mas, E., Beilin, L., Fenech, M., . . . Mori, T. (2016). n-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease. Nutrients, 8(3), 1-11.
    DOI Scopus14 WoS14 Europe PMC5
    2016 Mas, E., Barden, A., Burke, V., Beilin, L., Watts, G., Huang, R., . . . Mori, T. (2016). A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clinical Nutrition, 35(2), 331-336.
    DOI Scopus31 Europe PMC12
    2016 Barden, A., Mas, E., & Mori, T. (2016). n-3 Fatty acid supplementation and proresolving mediators of inflammation. Current Opinion in Lipidology, 27(1), 26-32.
    DOI Scopus26 Europe PMC16
    2016 Jiang, R., Hodgson, J., Mas, E., Croft, K., & Ward, N. (2016). Chlorogenic acid improves ex vivo vessel function and protects endothelial cells against HOCl-induced oxidative damage, via increased production of nitric oxide and induction of Hmox-1. Journal of Nutritional Biochemistry, 27, 53-60.
    DOI Scopus24 Europe PMC13
    2015 Barden, A., Mas, E., Croft, K., Phillips, M., & Mori, T. (2015). Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin. American Journal of Clinical Nutrition, 102(6), 1357-1364.
    DOI Scopus12 Europe PMC6
    2015 Barden, A., Burke, V., Mas, E., Beilin, L., Puddey, I., Watts, G., . . . Mori, T. (2015). N-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease. Journal of Hypertension, 33(9), 1947-1953.
    DOI Scopus16 WoS16 Europe PMC11
    2015 Caillaud, C., Mechta, M., Ainge, H., Madsen, A., Ruell, P., Mas, E., . . . Barrès, R. (2015). Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats. Journal of Endocrinology, 225(2), 77-88.
    DOI Scopus8 WoS6 Europe PMC6
    2015 Keelan, J., Mas, E., D'Vaz, N., Dunstan, J., Li, S., Barden, A., . . . Mori, T. (2015). Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction, 149(2), 171-178.
    DOI Scopus37 Europe PMC26
    2015 Melody, S., Vincent, R., Mori, T., Mas, E., Barden, A., Waddell, B., & Keelan, J. (2015). Effects of omega-3 and omega-6 fatty acids on human placental cytokine production. Placenta, 36(1), 34-40.
    DOI Scopus7 Europe PMC6
    2014 Barden, A., Mas, E., Croft, K., Phillips, M., & Mori, T. (2014). Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. Journal of Lipid Research, 55(11), 2401-2407.
    DOI Scopus40 Europe PMC28
    2014 Barden, A., Mas, E., Croft, K., Phillips, M., & Mori, T. (2014). Minimizing artifactual elevation of lipid peroxidation products (F <inf>2</inf>-isoprostanes) in plasma during collection and storage. Analytical Biochemistry, 449(1), 129-131.
    DOI Scopus24 Europe PMC11
    2013 Ramsden, C., Faurot, K., Zamora, D., Suchindran, C., Macintosh, B., Gaylord, S., . . . Mann, J. (2013). Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial. Pain, 154(11), 2441-2451.
    DOI Scopus78 Europe PMC54
    2013 Jones, M., Mark, P., Keelan, J., Barden, A., Mas, E., Mori, T., & Waddell, B. (2013). Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. Journal of Lipid Research, 54(8), 2247-2254.
    DOI Scopus34 Europe PMC26
    2013 Galano, J., Mas, E., Barden, A., Mori, T., Signorini, C., De Felice, C., . . . Durand, T. (2013). Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans. Prostaglandins and Other Lipid Mediators, 107, 95-102.
    DOI Scopus49 WoS41 Europe PMC17
    2012 Mas, E., Croft, K., Zahra, P., Barden, A., & Mori, T. (2012). Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clinical Chemistry, 58(10), 1476-1484.
    DOI Scopus151 Europe PMC109
    2012 Mubarak, A., Bondonno, C., Liu, A., Considine, M., Rich, L., Mas, E., . . . Hodgson, J. (2012). Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: A randomized trial. Journal of Agricultural and Food Chemistry, 60(36), 9130-9136.
    DOI Scopus53 Europe PMC36
    2012 MacHon, C., Thezenas, S., Dupuy, A., Assenat, E., Michel, F., Mas, E., . . . Cristol, J. (2012). Immunonutrition before and during radiochemotherapy: Improvement of inflammatory parameters in head and neck cancer patients. Supportive Care in Cancer, 20(12), 3129-3135.
    DOI Scopus17 WoS16 Europe PMC12
    2012 Simar, D., Malatesta, D., Mas, E., Delage, M., & Caillaud, C. (2012). Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation. Journal of Nutrition, Health and Aging, 16(2), 155-161.
    DOI Scopus12 WoS11 Europe PMC7
    2012 Barden, A., Corcoran, T., Mas, E., Durand, T., Galano, J., Roberts, L., . . . Mori, T. (2012). Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?. Antioxidants and Redox Signaling, 16(2), 165-169.
    DOI Scopus20 WoS20 Europe PMC14
    2011 Corcoran, T., Barden, A., Mas, E., Grape, S., Koren, V., Phillips, M., . . . Mori, T. (2011). Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery. Free Radical Biology and Medicine, 51(6), 1235-1239.
    DOI Scopus5 Europe PMC2
    2011 Corcoran, T., Mas, E., Barden, A., Durand, T., Galano, J., Roberts, L., . . . Mori, T. (2011). Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury?. Antioxidants and Redox Signaling, 15(10), 2663-2667.
    DOI Scopus29 WoS28 Europe PMC20
    2011 Mas, E., Barden, A., Corcoran, T., Phillips, M., Roberts, L., & Mori, T. (2011). Effects of spinal or general anesthesia on F <inf>2</inf> -isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery. Free Radical Biology and Medicine, 50(9), 1171-1176.
    DOI Scopus22 Europe PMC14
    2011 Barden, A., Mas, E., Henry, P., Durand, T., Galano, J., Roberts, L., . . . Mori, T. (2011). The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function. Free Radical Research, 45(4), 469-476.
    DOI Scopus22 WoS19 Europe PMC11
    2010 Mas, E., & Mori, T. (2010). Coenzyme Q<inf>10</inf> and statin myalgia: What is the evidence?. Current Atherosclerosis Reports, 12(6), 407-413.
    DOI Scopus26 Europe PMC16
    2010 Mas, E., Woodman, R., Burke, V., Puddey, I., Beilin, L., Durand, T., & Mori, T. (2010). The omega-3 fatty acids EPA and DHA decrease plasma F<inf>2</inf>- isoprostanes: Results from two placebo-controlled interventions. Free Radical Research, 44(9), 983-990.
    DOI Scopus65 WoS62 Europe PMC44
    2010 Yan, Z., Mas, E., Mori, T., Croft, K., & Barden, A. (2010). A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates. Analytical Biochemistry, 403(1-2), 126-128.
    DOI Scopus29 Europe PMC21
    2010 Chevassus, H., Gaillard, J., Farret, A., Costa, F., Gabillaud, I., Mas, E., . . . Petit, P. (2010). A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects. European Journal of Clinical Pharmacology, 66(5), 449-455.
    DOI Scopus34 WoS22 Europe PMC14
    2010 Mas, E., Barden, A., Durand, T., Galano, J., Croft, K., & Mori, T. (2010). Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances. Free Radical Research, 44(2), 191-198.
    DOI Scopus11 WoS11 Europe PMC9
    2010 Monnier, L., Colette, C., Mas, E., Michel, F., Cristol, J., Boegner, C., & Owens, D. (2010). Regulation of oxidative stress by glycaemic control: Evidence for an independent inhibitory effect of insulin therapy. Diabetologia, 53(3), 562-571.
    DOI Scopus106 WoS85 Europe PMC68
    2009 Dauvilliers, Y., Abril, B., Mas, E., Michel, F., & Tafti, M. (2009). Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology, 73(16), 1333-1334.
    DOI Scopus65 WoS61 Europe PMC36
    2008 Michel, F., Bonnefont-Rousselot, D., Mas, E., Drai, J., & Thérond, P. (2008). Biomarkers of lipid peroxidation: Analytical aspects. Annales de Biologie Clinique, 66(6), 605-620.
    DOI Scopus52 Europe PMC23
    2008 Delample, D., Durand, F., Severac, A., Belghith, M., Mas, E., Michel, F., . . . Prefaut, C. (2008). Implication of xanthine oxidase in muscle oxidative stress in COPD patients. Free Radical Research, 42(9), 807-814.
    DOI Scopus21 WoS17 Europe PMC14
    2008 Mas, E., Michel, F., Guy, A., Bultel, V., Falquet, Y., Chardon, P., . . . Durand, T. (2008). Quantification of urinary F<inf>2</inf>-isoprostanes with 4(RS)-F<inf>4t</inf>-neuroprostane as an internal standard using gas chromatography-mass spectrometry. Application to polytraumatized patients. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 872(1-2), 133-140.
    DOI Scopus22 WoS21 Europe PMC12
    2006 Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J. -P., & Colette, C. (2006). Glucose fluctuations and oxidative stress - Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 296(14), 1730-1731.
    DOI
    2006 Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J., & Colette, C. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 295(14), 1681-1687.
    DOI WoS1200 Europe PMC909
    2006 Mas, E., Dupuy, A., Artero, S., Portet, F., Cristol, J., Ritchie, K., & Touchon, J. (2006). Functional vitamin E deficiency in ApoE4 patients with Alzheimer's disease. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 21(3), 198-204.
    DOI WoS18 Europe PMC10
    2006 Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J., & Colette, C. (2006). Compared effects of the acute glycemic fluctuations and the chronic hyperglycemic on the activation of the stress oxidizing in the diabetic patients of type 2. DIABETES & METABOLISM, 32, S19.
    WoS2
    2005 Leger, C., Carbonneau, M., Michel, F., Mas, E., Monnier, L., Cristol, J., & Descomps, B. (2005). A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 59(5), 727-730.
    DOI WoS51 Europe PMC20
    2002 Cl, L., Leger, C., Visioli, F., Carbonneau, M., Michel, F., Mas, E., . . . Monnier, L. (2002). Hydroxytyrosol-enriched olive mill wastewater preparation (HTROW) decreases blood TXB2 and does not change urinary isoprostane production in healthy or diabetic subjects in two parallel intervention studies. FREE RADICAL BIOLOGY AND MEDICINE, 33, S195-S196.
    2001 Dupuy, A., Mas, E., Ritchie, K., Descomps, B., Badiou, S., Cristol, J., & Touchon, J. (2001). The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease. GERONTOLOGY, 47(4), 213-218.
    DOI WoS29 Europe PMC21
  • Book Chapters

    Year Citation
    2010 Mas, E., Cristol, J., & Michel, F. (2010). Biomarkers of lipid peroxidation: Quantification of isoprostanes and other oxidation products by mass spectrometry. In Handbook on Mass Spectrometry: Instrumentation, Data and Analysis, and Applications (pp. 225-246).
  • Conference Papers

    Year Citation
    2008 Michel, F., Bonnefont-Rousselot, D., Mas, E., Drai, J., & Thérond, P. (2008). Markers of oxidative stress: Biomarkers of lipid peroxidation. In Annales de Biologie Clinique Vol. 66 (pp. 698-701).
  • Position: Medical Scientist-Head Mass Spectrometry
  • Phone: 81617297
  • Email: emilie.mas@adelaide.edu.au
  • Campus: North Terrace
  • Building:
  • Org Unit: Faculty of Health and Medical Sciences

Connect With Me
External Profiles